↓ Skip to main content

Misperceptions About β‐Blockers and Diuretics

Overview of attention for article published in Journal of General Internal Medicine, December 2003
Altmetric Badge

Mentioned by

policy
1 policy source

Citations

dimensions_citation
44 Dimensions

Readers on

mendeley
21 Mendeley
Title
Misperceptions About β‐Blockers and Diuretics
Published in
Journal of General Internal Medicine, December 2003
DOI 10.1111/j.1525-1497.2003.20414.x
Pubmed ID
Authors

Peter A. Ubel, Christopher Jepson, David A. Asch

Abstract

Based on a series of clinical trials showing no difference in the effectiveness or tolerability of most major classes of antihypertensive medications, the Joint National Commission on High Blood Pressure Treatment recommends that physicians prescribe beta-blockers or diuretics as initial hypertensive therapy unless there are compelling indications for another type of medication. Nevertheless, many physicians continue to favor more expensive medications like angiotensin-converting enzyme (ACE) inhibitors and calcium channel blockers as first line agents. The persistent use of these agents raises questions as to whether physicians perceive ACE inhibitors and calcium channel blockers to be better than beta-blockers and diuretics. We surveyed 1,200 primary care physicians in 1997, and another 500 primary care physicians in 2000, and asked them to estimate the relative effectiveness and side effects of 4 classes of medication in treating a hypothetical patient with uncomplicated hypertension: ACE inhibitors, beta-blockers, calcium channel blockers, and diuretics. In addition, we asked them to indicate whether they ever provided free samples of hypertension medications to their patients. Perceptions of the relative effectiveness and side effects of the 4 classes of hypertension medications did not significantly change over the 3 years, nor did prescription recommendations. Physicians perceive that diuretics are less effective at lowering blood pressure than the other 3 classes (P <.001). They also perceive that beta-blockers are less tolerated than the other 3 classes (P <.001). In a multivariate model, perceptions of effectiveness and tolerability displayed significant associations with prescription preference independent of background variables. The only other variable to contribute significantly to the model was provision of free medication samples to patients. Despite numerous clinical trials showing no difference in the effectiveness or side-effect profiles of these 4 classes of drugs, most physicians believed that diuretics were less effective and beta-blockers were less tolerated than other medications. Moreover, their prescription practices were associated with their provision of free samples provided by pharmaceutical representatives, even after adjusting for other demographic characteristics. Efforts to increase physicians' prescribing of beta-blockers and diuretics may need to be directed at overcoming misunderstandings about the effectiveness and tolerability of these medicines.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Colombia 1 5%
Canada 1 5%
Unknown 19 90%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 14%
Student > Master 3 14%
Student > Doctoral Student 2 10%
Lecturer 1 5%
Professor 1 5%
Other 4 19%
Unknown 7 33%
Readers by discipline Count As %
Medicine and Dentistry 6 29%
Social Sciences 3 14%
Agricultural and Biological Sciences 2 10%
Nursing and Health Professions 1 5%
Psychology 1 5%
Other 0 0%
Unknown 8 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 January 2009.
All research outputs
#8,534,976
of 25,373,627 outputs
Outputs from Journal of General Internal Medicine
#4,427
of 8,173 outputs
Outputs of similar age
#36,408
of 143,682 outputs
Outputs of similar age from Journal of General Internal Medicine
#20
of 25 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,173 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.1. This one is in the 38th percentile – i.e., 38% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 143,682 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.